Rapid Forensic Cell Typing, Inc

Altri Biotherapeutics is a preclinical-stage pharmaceutical company based in Richmond, VA, specializing in the development of therapeutic monoclonal antibodies (mAbs) targeting the insulin-like growth factor (IGF) signaling system for cancer treatment. With a focus on triple-negative breast cancer (TNBC) and plans to expand into other metastatic and invasive cancers, Altri has licensed patents from Virginia Commonwealth University to advance its innovative therapeutic approaches. The company's lead candidate, ALT101, has demonstrated significant antitumor and antimetastatic activity in preclinical studies, particularly against TNBC, which disproportionately affects certain demographics and currently has limited treatment options. Altri aims to progress its therapeutic candidates toward IND filing and Phase III clinical trials, addressing critical unmet medical needs in cancer treatment. Generated from the website

Affinity Molecules LLC, based in Richmond, VA, specializes in providing custom cell line generation, protein antibody production, and purification services for research and therapeutics development. Their team of experienced scientists offers expertise in biological assay development and mycoplasma detection services, ensuring high-quality results for clients. Recently awarded the NIH Phase I grant, Affinity Molecules is known for their proficiency in large-scale in vitro production of mRNA-based vaccines using immobilized enzymes. With a focus on tailored solutions, they offer a range of expression and purification approaches to meet specific project requirements, making them a valuable partner in the biologics industry.Generated from the website

The Virginia Biotechnology Association, known as VirginiaBio, is dedicated to promoting the scientific and economic impact of the biotechnology industry within the Commonwealth of Virginia. Through strengthened networks, advocacy, capital investment, and talent development, the organization aims to foster innovation and growth in the life sciences sector. Generated from the website